COVID Vaccine Lawsuits Begin


Armstrong Economics Blog/Disease Re-Posted Aug 5, 2022 by Martin Armstrong

NorthShore University HealthSystem in Chicago was sued by a nonprofit religious organization called Liberty Counsel. The group claims that NorthShore violated workers’ religious autonomy by dismissing religious exemptions and forcing all workers to receive the COVID-19 vaccine. NorthShore was in the wrong and decided to settle for $10,337,500.

Over 500 current and past employees will receive a payout, and the group will notify others of the lawsuits and give them the option to submit a claim. “NorthShore will also change its unlawful ‘no religious accommodations’ policy to make it consistent with the law, and to provide religious accommodations in every position across its numerous facilities,” Liberty Counsel stated.

Other groups will follow suit. They may have granted the pharmaceutical companies immunity, but there was a grey area for employers. Countless people lost their jobs due to the vaccine mandate, which likely was a violation of the Constitution.

Lawsuits may begin with large corporations, but if the Republicans regain control, health agencies and government officials may be investigated as well. This lawsuit is a major win for medical autonomy as companies will be less likely to comply with government mandates as they now know they could risk legal retaliation.

Joe Biden Announces White House Monkeypox Response Team to Deliver “Health Equity to all Monkeypox Stakeholders”


Posted originally on the conservative tree on August 2, 2022 | sundance

I was unaware that monkeypox was an issue for the White House. However, today the Biden administration is proud to present a team of government officials tasked for the purpose of handling the whole of government response to the U.S. outbreak of monkeypox.

Additionally, I’m not exactly sure what a “stakeholder in monkeypox” is, but this team is in charge of making sure they have “health equity.”

WHITE HOUSE – “Today, President Biden named FEMA’s Robert Fenton as the White House National Monkeypox Response Coordinator and Dr. Demetre Daskalakis as the White House National Monkeypox Response Deputy Coordinator. Fenton and Daskalakis will lead the Administration’s strategy and operations to combat the current monkeypox outbreak, including equitably increasing the availability of tests, vaccinations and treatments.

[…]  “Bob Fenton and Dr. Daskalakis are proven, effective leaders that will lead a whole of government effort to implement President Biden’s comprehensive monkeypox response strategy with the urgency that this outbreak warrants,” said Anthony Fauci, Chief Medical Advisor to the President. “From Bob’s work at FEMA leading COVID-19 mass vaccination efforts and getting vaccines to underserved communities to Demetre’s extensive experience and leadership on health equity and STD and HIV prevention, this team will allow the Biden Administration to further accelerate and strengthen its monkeypox response.”

Fenton and Daskalakis will coordinate and manage response efforts across the White House and all Federal departments and agencies. They will work with local, state, national, and international stakeholders on tracking and fighting the spread of monkeypox, with state and local partners to ensure they have adequate supplies to test, treat and vaccinate at-risk individuals, with clinicians and providers on available testing, treatment and vaccination options, and with stakeholder communities on building public understanding of the virus and how to address it most effectively.

[…] Over the coming weeks, under the leadership of Fenton and Daskalakis, the Administration will advance and accelerate the United States’ monkeypox response to mitigate the spread of the virus, protect individuals most at risk of contracting the virus, and care for those who have been afflicted with it.” (read more)

White House Covid Vaccine Summit: A Good Day for Big Pharma


Arnie Mazer Writer at TrialSite News where it was originally posted on Jul. 26, 2022, 6:30 p.m.

Opinion Article

The White House hosted a “Summit on the Future of the Covid-19 Vaccine” on Tuesday featuring a combination of administration officials, scientists, and executives from the pharmaceutical industry. The summit was chaired by Dr. Ashish Jah, the White House Covid-19 Response Coordinator. Attendees included Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases (NIAID), as well as Dr. Francis Collins, the former head of the National Institutes of Health (NIH). Also in attendance were the representatives of pharmaceutical companies, including Moderna and Pfizer. There is no question the advent of vaccines blunted the complete force of the Covid-19 pandemic as Fauci pointed out in his address to the group. He said that “vaccines have saved over 2 million lives and prevented 17 million hospitalizations” even though the World Health Organization pointed out, initially, the vaccines were not distributed equitably among poor nations while the pharmaceutical companies were reaping profits. But the emphasis of the Summit was on how vaccines will be developed and distributed.  

Big Pharma at the Summit

In his opening remarks, Dr. Jah extolled vaccines, saying they are “truly a miracle of human ingenuity and 70% of Americans are now vaccinated.” But Jah also said vaccines “need to be better.” Fauci talked about science and manufacturing working together to make sure vaccines are distributed equally and the private sector and science are working together to advance vaccine technology. Additionally, it was pointed out the Biden Administration is committed to the development of new vaccines. Fauci then presented slides of the projects the NIH was funding and developing with vaccine manufacturers. 

Included in this was a “Mosaic Approach,” a new form of vaccine that takes on multiple parts of the virus and could help protect against future Covid variants. Participating in the summit were Paul Burton of Moderna and Angela Hwang of Pfizer. Fauci’s presentation of the future of vaccines included the idea that vaccines need to be updated because the Covid virus is continually mutating.  

He emphasized the partnership between academia and the private sector. As effective as Fauci’s speech was, it also seemed as if he was giving free advertising to the drug companies with the idea of maximizing the benefits of the partnership of science and technology.  The transformative power of the new generation of vaccines continued to be pointed out and regional manufacturing of vaccines was repeatedly pointed to as a way to get more shots in arms. This point came from both Ashish Jah and Angela Hwang. Regional manufacturing and licensing is a way for pharmaceutical companies to increase profit. Moderna’s Paul Burton said manufacturing is a key part of the future, and the company had recently made deals to build new plants in Australia, the United Kingdom, Canada, and Kenya. In the future, vaccines will be administered through nasal sprays and patches. Angela Hwang pointed out that “probably two and a half billion people have received the Pfizer vaccine. That’s an incredible wealth of real-world evidence that we’re sitting on… I think that we have a great opportunity to also help us to understand, how can we design new therapies.” Hwang added Pfizer is “happy to be on this journey.”

mRNA Vaccines Originated with the Department of Defense

The summit gave a history of the mRNA vaccine and said the potion originated through a part of the Department of Defense known as the Defense Advanced Research Projects Agency (DARPA). The development of the vaccine came as a result of research to help American troops if they’d been exposed to biological warfare on the battlefield. Through that program and others, DARPA had been doing the groundwork for the United States to produce a rapid cure for a pathogen like Covid-19 for years. The pharmaceutical companies capitalized on developed technology and took it further. 

Transparency Emphasized

Summit panels continually talked about the fact not enough of the population has been vaccinated, and Dr. Francis Collins claimed the pandemic exposed the vulnerability of the American health care system. Collins said there was a need to build public trust even though, initially, the vaccines were not “distributed with equity.” This included the fact that the World Health Organization’s (WHO) Covid-19 Vaccines Global Access (COVAX) has to do a better job of vaccine distribution through what was termed an “allocation framework”.  In closing, Dr. Ashish Jah emphasized, again, the importance of public and private partnerships. The summit was, overall, informative and a great day for the pharmaceutical companies. 

The impact of such governmental backing of just a few companies most certainly reinforces the market brand. The presenters didn’t do much reflection as to what they could have done better during the pandemic. Rather, industry and government collaboration on more advanced vaccines suggests the government will increasingly be involved in helping fund the few winners of the vaccine and drug development business.

Double Vaxxed, Double Boosted, Loaded with Paxlovid, Joe Biden Gets COVID Again


Posted originally on the conservative tree house on July 30, 2022 

Well, isn’t that convenient.   Sorry folks, I can’t come out and take questions, I’ve got the Rona again.

[SOURCE]

Only the second thing that has been positive during his tenure.

[Source Link pdf]

Double Vaxxed, Double Boosted Joe Biden Has COVID-19 Again, Will Work in Isolation


Posted originally on the conservative tree house on July 21, 2022 | Sundance

Suspicious Cat remains, well, suspicious…

[White House Press Release] – This morning, President Biden tested positive for COVID-19.  He is fully vaccinated and twice boosted and experiencing very mild symptoms.  He has begun taking Paxlovid. Consistent with CDC guidelines, he will isolate at the White House and will continue to carry out all of his duties fully during that time.  He has been in contact with members of the White House staff by phone this morning, and will participate in his planned meetings at the White House this morning via phone and Zoom from the residence. 

Consistent with White House protocol for positive COVID cases, which goes above and beyond CDC guidance, he will continue to work in isolation until he tests negative.  Once he tests negative, he will return to in-person work.

Out of an abundance of transparency, the White House will provide a daily update on the President’s status as he continues to carry out the full duties of the office while in isolation.

Per standard protocol for any positive case at the White House, the White House Medical Unit will inform all close contacts of the President during the day today, including any Members of Congress and any members of the press who interacted with the President during yesterday’s travel.  The President’s last previous test for COVID was Tuesday, when he had a negative test result. (read more)

CDC Stops Reporting Cruise Ship COVID Outbreaks


Armstrong Economics Blog/Corruption Re-Posted Jul 21, 2022 by Martin Armstrong

The Centers for Disease Control and Prevention (CDC) will no longer report COVID outbreaks on cruise ships. Per the CDC’s website:

“As of July 18, 2022, CDC’s COVID-19 Program for Cruise Ships is no longer in effect. CDC will continue to publish guidance to help cruise ships continue to provide a safer and healthier environment for passengers, crew and communities going forward.”

Clearly, this is an attempt to hide the fact that the vaccinated are spreading and contracting COVID, possibly more frequently than the unvaccinated. Nearly all cruise liners have required staff and passengers to be “fully vaccinated” before boarding. Yet, there are countless stories of COVID outbreaks on ships with 100% vaccination rates. So the cruise industry lost over $63 billion between 2020 and 2021 for absolutely no reason.

The CDC still recommends that vacationers take a COVID test before boarding and adhere to all their guidelines. The agency now claims that the liners simply have access to their guidance and they no longer need to control the situation. In reality, they cannot explain why ships containing fully vaccinated passengers and staff are experiencing outbreaks. Answer: THE VACCINE DOES NOT WORK!

Infection-enhancing antibodies either ‘drain’ or ‘train’….


2 comments

Geert Vanden Bossche, DVM, PhD

General Manager at Voice for Science and Solidarity | The biggest challenge in vaccinology: Countering immune evasion

Published originally on TS News on Jul. 16, 2022, 9:00 p.m.

Weak immune activation by glycosylated ASLI- or ASLD-enabling viruses (that occurs, for example, during asymptomatic-mild natural infection) elicits low concentrations of non-neutralizing, short-lived IEABs. Upon subsequent re-exposure to a homologous or antigenically shifted[1] viral lineage these Abs are highly likely to enhance viral uptake by susceptible host cells and contribute to innate immune training of pre-primed NK cells. However, it’s important to note that individuals who contract asymptomatic/ mild infection provoked by a glycosylated ASLVI- or ASLVD-enabling virus can still experience disease. This can occur when re-exposure to the homologous or antigenically shifted viral lineage occurs at a point in time where the short-lived non-neutralizing IEABs are at their very highest level. As these Abs are immature (i.e., non-functional), their titers decline rapidly—they are no longer even detectable after 8 weeks. ADED after asymptomatic/ mild infection is therefore rare and the incidence rate thereof can only significantly increase in case of high viral infectiousness (which will substantially increase the likelihood for re-infection within just a few weeks after the previous asymptomatic-mild infection). In the case of SC-2, high viral infectiousness results from natural selection and dominant propagation of ‘more infectious’ SC-2 variants which is a direct consequence of mass vaccination (as previously explained).  

On the other hand, immune priming by glycosylated ASLI- or ASLD-enabling viruses (for example, in people who contract the disease) induces virus-neutralizing Abs as well as non-neutralizing Abs (comprising IEABs). Upon subsequent re-exposure to an antigenically shifted viral lineage binding of the IEABs to a variant-nonspecific site[2] on the virus enhances viral uptake by susceptible host cells. This partially sidelines pre-primed NK cells and calls on cytotoxic CD8+ T cells to clear virus-infected cells, leading to more pronounced symptoms of disease. As the enhanced viral uptake does not usually lead to full drainage of the viral clearance capacity of cytotoxic CD8+ T cells, productive infection will not only enhance training of pre-primed NK cells but also enables priming of ‘new’ Abs directed at the surface protein that is responsible for initiation of infection by the antigenically shifted viral lineage. 

This can explain why individuals who contracted disease induced by a glycosylated ASLVI- or ASLVD-enabling virus can still contract disease again (but rarely severe) up to several months after their recovery. This typically occurs when re-infection is caused by an antigenically shifted viral lineage and at a point in time where the naturally induced Ag-specific Abs are still fairly high. The phenomenon can also occur in the case vaccine-induced Abs are confronted with an antigenically shifted viral lineage before they have achieved full-fledged neutralizing capacity. Individuals who got partially vaccinated (e.g., only one shot) with a non-replicating Ab-based viral vaccine and become exposed to an antigenically shifted viral lineage shortly thereafter are prone to this risk. 

Finally, strong immune priming by non-replicating Ab-based vaccines elicits high concentrations of both potentially neutralizing and non-neutralizing IEABs.  Upon subsequent re-exposure to an antigenically shifted viral lineage the IEABs are highly likely to enhance viral uptake by susceptible host cells in a way that sidelines pre-primed NK cells and increasingly drains the flow capacity of viral clearance by cytotoxic CD8+ T cells (instead of training NK cells). This is likely to not only cause more severe disease and delay recovery, but also to prevent immune priming against the antigenically shifted epitopes (immunologically outcompeted by ‘old’ epitopes that benefit from ‘antigenic sin’). Instead, natural re-exposure to either a homologous or antigenically shifted viral lineage will strongly boost the IEABs for lack of sufficient flow capacity of viral clearance by cytotoxic CD8+ T cells (as a result of deficient NK cell training). In case of re-infection with the same viral variant, this is likely to increase the severity of the disease (due to ADEI) whereas re-exposure to an antigenically shifted viral lineage that is resistant to the potentially infection-neutralizing vaccine-induced Abs (e.g., the more virulent Omicron BA.4 or BA.5 lineages in case of SC-2) will enable boosted IEABs to protect against severe disease (via inhibition of productive trans infection in the LRT).

In the meantime, viral lineages that are resistant to the potentially virulence-neutralizing vaccinal Abs are being selected. Once this has happened, the IEABs will facilitate ADEI-mediated ADED in vaccinees. 

Conclusion in regard of SC-2 and Covid-19

Whereas the unvaccinated are experiencing increasing and durable protection from C-19 disease caused by new variants through i) trained innate immunity (which is not susceptible to immune escape!) and ii) priming of new neutralizing Abs against those variants (as ‘antigenic sin’ is mitigated by trained innate immunity!), vaccinees now need to exclusively rely on boosting (as ‘antigenic sin’ is not mitigated by training of pre-primed NK cells) of IEABs (which are prone to immune escape!) to ensure a fragile and provisional protection from severe disease.

Whereas immune training is a blessing, immune drainage is a scourge! That’s why only natural immunity can eventually fully protect you during a pandemic. That’s why Africa will win!    

Bibliography:

[1]  ‘Antigenically shifted’ relates to an antigenic shift in the viral surface protein that is responsible for initiation of infection

[2]  In case of SC-2, this site is situated within the N-terminal domain of spike protein

AntibodiesCOVID-19SARS-CoV-2

Fauci Set to Retire


Armstrong Economics Blog/Corruption Re-Posted Jul 19, 2022 by Martin Armstrong

Dr. Anthony Fauci, Mr. COVID himself, announced that he would retire at the end of Joe Biden’s term. Fauci hinted in an interview that he fears an investigation into his personal dealings if the conservatives take back control next year. “They’re going to try and come after me, anyway. I mean, probably less so if I’m not in the job,” Fauci told Politico. We know the vaccination does not work and causes more harm than good. The long-term effects of the vaccines and lockdowns are now coming to light, and Fauci is responsible as the mascot for the entire COVID agenda.

Fauci maintains that boosters will be necessary every year, similar to the flu vaccine, despite the components of the two vaccines differing drastically. Fauci also admitted that the people are waking up to the fear-mongering and brainwashing techniques he used to scare the world to stay inside.

“It’s becoming more and more difficult to get people to listen, because even the people who are compliant want this behind them,” Fauci said, bewildered that people do not obey his every word. “What I try to convince them [of], with my communication method, is we’re not asking you to dramatically alter your lifestyle. We’re not asking you to really interfere with what you do with your life. We’re just asking you to consider some simple, doable mitigation methods.”

The ”simple, doable mitigation methods” involved involuntary house arrest, school closures, business closures, and forced vaccinations of an EXPERIMENTAL mRNA gene-altering therapy. These policies were a gut punch to the global economy. Countless people lost their jobs and lives due to his warped God-complex view of “trust the science.” This man should be held accountable for the damage he has done to society – permanent damage that will linger for generations to come.

The Disease Cycle


Armstrong Economics Blog/Disease Re-Posted Jul 11, 2022 by Martin Armstrong

QUESTION: Marty, You have forecasted that your disease model turned up here in 2022. COVID was exploited, but it was no worse than the flu. Then there is monkeypox. But the latest is the much more lethal Marburg virus in Africa. Is this going to be the real one?

DC

ANSWER: The model did not target a specific virus. There are serious outbreaks throughout history but they are not always the same virus or bacteria. The history of this particular virus only goes back to 1967. This particular virus has a base cycle of 5-year intervals. The major outbreak was 2004-2005 which lasted into 2008. Ideally, our model projected that would reappear in 2013 and it showed up in 2012 a little ahead of schedule.

A major outbreak should come in the 2027-2028 time period. But keep in mind that this has not turned into a pandemic and has been confined to Africa. It is spread through bodily fluids so which usually involves sex or touching an open sore. So I would not be concerned that this will spread to your neighborhood without human intervention. The most devastating disease cycle will be from 2027 into 2050.

Tucker Carlson Outlines How the COVID-19 Pandemic Reset Everything and asks, Was it Done on Purpose?


Posted originally on the conservative tree house on July 9, 2022 | Sundance

During his opening monologue Friday evening, Fox News host Tucker Carlson went into great detail outlining the current evidence of how the SARS-CoV-2 virus originated.

As a direct consequence of the COVID-19’s global impact, a geopolitical reset has taken place.  Carlson asks the questions of whether this reset was done purposefully, and why is there no one looking at how the virus originated?   WATCH: